Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04835597 · ClinicalTrials.gov registry record
Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 27
- Enrollment target
NCT04835597: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT04835597 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04835597 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 27 participants
- Enrollment target
Study Summary
This study assesses the performance status in stage I-III triple negative breast cancer patients who are receiving neoadjuvant chemotherapy. Information collected in this study may help doctors learn if movement and fitness trackers can be used to predict side effects in cancer patients receiving chemotherapy.
Interventions
- OTHER Electronic Health Record Review
- BEHAVIORAL Behavioral Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2022-08-15 |
| Est. Completion | 2024-08-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04835597
The ClinicalTrials.gov registry entry for NCT04835597 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Electronic Health Record Review is the first listed.
NCT04835597 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04835597 about?
NCT04835597 is a clinical study titled "Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy". This study assesses the performance status in stage I-III triple negative breast cancer patients who are receiving neoadjuvant chemotherapy. Information collected in this study may help doctors learn if movement and fitness trackers can be used to predict side effects in cancer patients receiving ch...
What is the current status of trial NCT04835597?
This trial is currently terminated. The enrollment target is 27 participants. The study started on 2022-08-15. Estimated completion is 2024-08-21.
What interventions are being tested in trial NCT04835597?
The interventions under investigation include: Electronic Health Record Review (OTHER), Behavioral Assessment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04835597?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.